Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2008 1
2009 1
2011 1
2015 1
2020 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
[Pharmacological treatment in early rehabilitation after ischemic stroke].
Pigretti SG, Isaac C, Cea C, Esnaola MM, Riveros M, Tejada Jacob V, Weinberg M, Posadas Martinez ML, Cirelli D, Burgos MA, Zimerman M, Romano M. Pigretti SG, et al. Among authors: esnaola mm. Medicina (B Aires). 2023 Aug;83 Suppl 3:1-40. Medicina (B Aires). 2023. PMID: 37624681 Free article. Review. Spanish.
Cerebral venous thrombosis in Argentina: clinical presentation, predisposing factors, outcomes and  literature review.
Alet M, Ciardi C, Alemán A, Bandeo L, Bonardo P, Cea C, Cirio J, Cossio J, Cuculic M, Esnaola MM, García-Pérez F, Giner F, Gómez-Schneider M, Isaac C, Lepera S, Martínez C, Martínez-Lorenzín R, Montes M, Orzuza G, Persi G, Povedano G, Pujol-Lereis V, Quiroga-Narváez J, Romano M, Sabio R, Viglione J, Zurrú MC, Saposnik G; Argentinian Stroke and Cerebrovascular Diseases Study Group - Argentine Neurological Society. Alet M, et al. Among authors: esnaola mm. J Stroke Cerebrovasc Dis. 2020 Oct;29(10):105145. doi: 10.1016/j.jstrokecerebrovasdis.2020.105145. Epub 2020 Jul 28. J Stroke Cerebrovasc Dis. 2020. PMID: 32912503 Review.
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici MG, Mattle HP, Rothwell PM; PERFORM Study Investigators. Bousser MG, et al. Cerebrovasc Dis. 2009;27(5):509-18. doi: 10.1159/000212671. Epub 2009 Apr 16. Cerebrovasc Dis. 2009. PMID: 19372653 Free article. Clinical Trial.